Regeneron stock touches 52-week low at $735 amid market shifts

Dec 13, 2024 · In a challenging market environment, Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) stock has reached its 52-week low, dipping to $735.According to InvestingPro data, …

$735
OFF

Regeneron Stock Touches 52-week Low At $735 Amid Market Shifts

2 weeks from now

Dec 13, 2024 · In a challenging market environment, Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) stock has reached its 52-week low, dipping to $735.According to InvestingPro data, …

investing.com

$735
OFF

Regeneron Stock Touches 52-week Low At $735 Amid Market Shifts

2 weeks from now

Dec 13, 2024 · In a challenging market environment, Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) stock has reached its 52-week low, dipping to $735.According to InvestingPro data, …

investing.com

$735
OFF

Regeneron Stock Touches 52-week Low At $735 Amid Market Shifts

2 weeks from now

Regeneron stock touches 52-week low at $735 amid market shifts

investing.com

$692.81
OFF

Regeneron Stock Touches 52-week Low At $692.81 Amid Market Shifts

2 weeks from now

5 days ago · With a market capitalization of $74.85 billion and a P/E ratio of 16.25, the stock appears undervalued based on InvestingPro's Fair Value analysis. Over the past year, …

investing.com

$731.80
OFF

Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 12-Month …

2 weeks from now

Dec 14, 2024 · Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Get Free Report)'s share price reached a new 52-week low on Friday . The stock traded as low as $731.80 and last …

marketbeat.com

$735
OFF

Regeneron Pharmaceuticals Inc (REGN34) - Investing.com

2 weeks from now

Regeneron stock touches 52-week low at $735 amid market shifts In a challenging market environment, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) stock has reached its 52 …

investing.com

43%
OFF

Regeneron Stock Hits 52-week Low Amid Mixed Ratings - REGN

2 weeks from now

Regeneron Pharmaceuticals (NASDAQ:REGN) stock reached a 52-week low at $785.31, reflecting a 0.43% decline over the past year. The company announced an 11% increase in …

investingsnacks.com

$692.81
OFF

Regeneron Stock Declines To New Low: The Future Ahead

2 weeks from now

6 days ago · Regeneron Stock Hits 52-Week Low. Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) has recently witnessed a significant downturn, marking a 52-week low of $692.81. This …

investorshangout.com

10%
OFF

Regeneron Pharmaceuticals Down Nearly 10%, On Track For

2 weeks from now

Oct 31, 2024 · Regeneron Pharmaceuticals, Inc. (REGN) is currently at $832.76, down $90.03 or 9.76% --Would be lowest close since Dec. 5, 2023, when it closed at $820.90 --On pace for …

morningstar.com

$692.81
OFF

REGN Stock Price - Regeneron Pharmaceuticals Inc Stock

2 weeks from now

6 days ago · Regeneron Pharmaceuticals Inc (REGN) Stock Price, Chart, Latest News, Technical Indicator, Option Chain and much more. ... Regeneron stock touches 52-week low at $692.81 …

stockscan.io

41%
OFF

Is Regeneron Absurdly Cheap Or Has It Become A Value Trap?

2 weeks from now

Jun 16, 2022 · So far in 2022, Regeneron Pharmaceuticals (REGN 0.41%) stock has fallen by 14%. It recently hit a new 52-week low and trades at an incredibly low earnings multiple.

fool.com

43%
OFF

Regeneron Stock Touches 52-week Low At $785.31 - Investing.com

2 weeks from now

Nov 14, 2024 · Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) stock has reached its 52-week low, trading at $785.31.This price level reflects a subtle yet notable decline of 0.43% …

investing.com

32%
OFF

Regeneron (REGN) Loses -11.32% In 4 Weeks, Here's Why A Trend …

2 weeks from now

Oct 10, 2024 · Regeneron (REGN) has been on a downward spiral lately with significant selling pressure. After declining 11.3% over the past four weeks, the stock looks well positioned for a …

yahoo.com

$692.81
OFF

Regeneron Stock Touches 52-week Low At $692.81 Amid Market Shifts

2 weeks from now

6 days ago · Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) stock has experienced a notable downturn, touching a 52-week low of $692.81.According to InvestingPro data, the …

investing.com

43%
OFF

Regeneron Stock Touches 52-week Low At $785.31 - Investing.com …

2 weeks from now

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) stock has reached its 52-week low, trading at $785.31. This price level reflects a subtle yet notable decline of 0.43% over the past year, …

investing.com

100%
OFF

Amgen Stock Touches 52-week Low At $257.77 Amid Market Shifts

2 weeks from now

Dec 19, 2024 · Plan ahead with key data on upcoming stock reports - all in 1 place See Calendar Get 100% ad-free experience Amgen stock touches 52-week low at $257.77 amid market shifts

investing.com

FAQs about Regeneron stock touches 52-week low at $735 amid market shifts Coupon?

What is the Regeneron Pharmaceuticals 52-week low stock price?

The Regeneron Pharmaceuticals 52-week low stock price is 769.19. This price is 32.8% below the current share price. The average Regeneron Pharmaceuticals stock price for the last 52 weeks is 949.11. ...

Will Regeneron Pharmaceuticals' recent moves change its short- and long-term prospects?

The company has made some recent moves that could change its short- and long-term prospects. So far in 2022, Regeneron Pharmaceuticals ( REGN -0.23%) stock has fallen by 14%. It recently hit a new 52-week low and trades at an incredibly low earnings multiple. ...

What is the closing price for Regeneron Pharmaceuticals?

The latest closing stock price for Regeneron Pharmaceuticals is 1144.77 as of September 09, 2024. ...

Is Regeneron stock cheap?

Regeneron stock is trading at a forward price-to-earnings (P/E) multiple between 12 and 13. That's cheaper than the average stock on the Health Care Select Sector SPDR Fund, where the multiple is around 15 -- a discount, but not at an astronomical one. Its trailing P/E of less than 8 certainly looks low. ...

Is Regeneron (regn) ripe for a trend reversal?

The heavy selling pressure might have exhausted for Regeneron (REGN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal. ...

What does Regeneron Pharmaceuticals do?

Regeneron Pharmaceuticals is a biotechnology company focused on the discovery, development, and commercialization of treatments targeting serious medical conditions. Its portfolio includes nine marketed drugs such as Eylea, Dupixent, Praluent, Kevzara, and more. ...